Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Clinical trial NCT03253094 · COMPLETED
Trial details
- NCT number
- NCT03253094
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2018-05-04
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.